Drugs against HIV

July 30, 2018 – 00:00
Depending on the studies, you can do a treatment with two and not three pills.

The Scientific Director of Fundación Huésped, Pedro Cahn, specialist in infectious diseases, presented the results of the Gemini study, which shows that a two-drug regimen (Dolutegravir and Lamivudine) has an efficacy similar to that of the three drugs in HIV patients and that they have never received treatment, regardless of the viral load that they present when they start it.

This was done as part of the 22nd International AIDS Conference (Aids 2018) which took place this Friday in Amsterdam.

Cahn, principal investigator of the study, noted that "during the last 15 or 20 years, the standard of HIV treatment revolved around a three-drug regimen, and now that we have some more powerful drugs, this approach aims to improve tolerability. and convenience. "" The Gemini study has shown that we can achieve the effectiveness of the use of three drugs in a diet of two with the tolerability and interaction of a diet of 3 drugs ", said the researcher.

Argentine project
the participation of more than 1,400 HIV-positive people who had not been treated before in Europe, the Americas, Africa and the Asia-Pacific region. Pacific, and was based on precedents established in the Paddle Study, a pilot project conducted in Argentina by the team of researchers from the Fundación Huésped, who used the same research question .Paddle continued the line from the GardelL study (designed by Fundación Huésped), which showed that dual therapy with lamivudine regimens was as effective as triple therapy